definiens: means with respect to a given country of the Territory, the written notification to Licensor byLicensee that the sale in a given country of the Territory of one or more products containing IGF-1 produced in a prokaryoticexpression system by one or more third parties that are not Sub - licensees of Licensee has achieved greater than twenty - fivepercent ( 25 % ) Market Share . For purposes of this Section 1.64, shall mean the percentage market share in valuefor the product or products in question containing IGF-1, such percentage to be established by measuring a full Calendar Quarterof reported prescription data for the applicable product(s ) and any competing products ( including Licensed Products ) sold in therelevant country of the Territory . If the Parties are unable to mutually agree on the Market Share of a given product or productsbased on such prescription data, the Parties shall submit the issue to a mutually - agreeable third party market research firmhaving expertise in pharmaceutical sales in the relevant country of the Territory ( the ) . The Research Firm shallbe instructed to provide an independent assessment of the Market Share for purposes of determining Market Competitionhereunder . Licensee shall bear all costs associated with the services of the Research Firm ; provided that in the event that theResearch Firm establishes that the Market Share is twenty five percent ( 25 % ) or higher for a particular Indication, Licensor shallreimburse Licensee for the full cost of the Research Firm ’s services for such assessment